Tissue

Search documents
Kimberly-Clark (NYSE:KMB) FY Conference Transcript
2025-09-10 15:32
Kimberly-Clark FY Conference Summary Company Overview - **Company**: Kimberly-Clark (NYSE: KMB) - **Industry**: Consumer Packaged Goods (CPG) - **Conference Date**: September 10, 2025 Key Points Transformation and Portfolio Reshaping - Kimberly-Clark has evolved from an industrial company to a consumer-focused CPG company over the last few decades, with a significant shift occurring since the late 1980s and early 1990s [2][3] - The company has focused on premium, value-added offerings and brand building, enhancing consumer-centric capabilities [1][4] - The CEO highlighted the importance of consumer insights and marketing execution in driving growth [4][5] Financial Performance and Growth - Since the CEO's tenure began, Kimberly-Clark has achieved a compounded organic growth rate of approximately 4% [5] - The company has historically faced challenges with lower gross margins and higher EPS volatility compared to peers, primarily due to pulp cost exposure [5][6] - A joint venture with Suzano, a major eucalyptus pulp producer, aims to reduce volatility and improve visibility into the tissue business [6][8] 2030 Financial Targets - Kimberly-Clark aims for a 40% gross margin and 18% EBITDA by 2030, with expectations to reach these milestones ahead of schedule due to portfolio changes [9][10] - The company has initiated a $3 billion productivity program over five years, tracking ahead of schedule [10][11] Advertising and Brand Building - The company has significantly increased advertising investments, from $500 million to $600 million, focusing on digital channels for better targeting [18][19] - Kimberly-Clark has received recognition for its advertising efforts, winning 11 Lion Awards at Cannes, more than doubling its previous five-year total [19][20] Innovation and Product Development - The company emphasizes product superiority and engineering capabilities as foundational principles [22][23] - An innovative absorbent core technology for diapers has been successfully rolled out in multiple markets, contributing to market share growth [23][24] - R&D investments are healthy, at approximately 1.9% of net sales, with CapEx increasing from 3.6% to 4.3% of net sales [26][27] Market Dynamics and Challenges - The diaper category has seen subdued growth due to increased promotional activity and competition from private labels, with recent growth at around 1% [29] - The company is strategically avoiding participation in aggressive promotional activities to maintain brand integrity [29] Future Outlook - Kimberly-Clark is positioned as a more capable company than a decade ago, with reduced earnings volatility and a strong innovation pipeline [32][33] - The company is focused on becoming world-class in productivity, with a target of achieving around 6% productivity growth this year [33] Conclusion - Kimberly-Clark is optimistic about its future, emphasizing a lean, agile operating model and a commitment to winning in local markets [34]
Suzano & Kimberly-Clark to Form Global Tissue Joint Venture
ZACKSยท 2025-06-06 14:32
Group 1: Joint Venture Announcement - Suzano S.A. and Kimberly-Clark Corporation are forming a $3.4 billion joint venture to manufacture consumer and professional tissue products, with Suzano owning 51% and Kimberly-Clark holding 49% [1][7] - The joint venture will be incorporated in the Netherlands and will operate 22 manufacturing facilities across 14 countries, with an annual tissue production capacity of approximately 1 million tons and projected net sales of $3.3 billion in 2024 [2][3][7] Group 2: Market and Employment Impact - The joint venture will market and distribute various tissue products in over 70 countries and is expected to create more than 9,000 job opportunities [3] - The transaction is anticipated to close in mid-2026, with Suzano set to pay $1.734 billion in cash at closing, subject to standard post-closing adjustments [4][7] Group 3: Suzano's Financial Performance - In Q1 2025, Suzano reported net sales of $1.97 billion, an increase from $1.91 billion in the same quarter of the previous year, with adjusted earnings rising to 87 cents compared to 3 cents in the prior year [5] - Over the past year, Suzano's shares have increased by 5.9%, while the industry has seen an 18.4% growth [6]